HAVCR2 and hepatocellular carcinoma: lncRNA NEAT1 is increased in the peripheral blood mononuclear cells (PBMCs) of patients with HCC, which decreases the antitumor activity of CD8 + T cells against HCC by regulating the miR-155/Tim-3 axis [141].